Addison Snell, vice president and general manager of Tabor Research, provides views of high performance computing in the bio sciences area at an Intel® Xeon® processor 5500 series launch event for the pharmaceutical industry.
Tabor Communications: High performance computing and bio sciences
3.22MB, PDF
At the Intel® Xeon® processor 5500 series launch event for the pharmaceutical industry, REvolution Computing discussed how REvolution R Enterprise improves the performance of widely-used tools in gene expression microarray analysis, and how they’ve seen real-world performance gains with the new Intel Xeon processor.
1.36MB, PDF
Shai Ofek, Lead Technical Product Manager for Microsoft, provides insights on Windows Server* 2008 R2, System Center Virtual Machine Manager and server virtualization with Hyper-V at the Intel® Xeon® processor 5500 series launch event.
Microsoft and Intel Virtualization
2.42MB, PDF
Intel’s Kevin Watson, Director of Enterprise Marketing for the Server Platform Group, provides an overview of the new Intel® Xeon® Processor 5500 Series in his keynote at a launch event for the pharmaceutical industry.
Transform: Intel® Xeon® Processor 5500 Series
7.96MB, PDF